RxDoctor Payments Data

Christopher Davies, MD

Pain Medicine · Duluth, MNNPI 1194165050

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 41.9% of the total. Reporting peaked in 2023 at $5,588 and has fallen 89.7% since, to $578 in 2025.

$16,246in general payments, 2019–2025

Across 435 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • MML US, Inc.$3K
  • Relievant Medsystems, Inc.$2K
  • Arthrex$1K
  • Medtronic$1K
  • Si-bone, Inc.$959
  • plus $1K from 9 others
$9,396in research payments, 2019–2025

Across 4 payments — averaging $2349.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$9K

What the payments were for

  • Travel & lodging$5,96037%
  • Food & beverage$9,08656%
  • Education$1,2007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,246 in reported general payments places this provider in the 80th percentile of 88 pain medicine providers in Minnesota.

See all pain medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$73,004
Medicare patients
273
Services billed
731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl22$3,575
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen133$2,789
Metaxalone13$1,511
Gabapentin104$1,461
Methadone Hcl31$1,210
Oxycodone Hcl62$1,172
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$1,021
Morphine Sulfate17$731
Methocarbamol37$631
Baclofen32$544
Ciprofloxacin Hcl89$537
Duloxetine Hcl28$519
Hydromorphone Hcl20$477
Tramadol Hcl57$406
Pregabalin56$405

Paid to pharmacies, not to this prescriber.

Other pain medicine in Duluth

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →